Toxic effect of high concentration of sonochemically synthesized polyvinylpyrrolidone-coated silver nanoparticles on Citrobacter sp.A1 and Enterococcus sp.C1 by Lau, Chew Ping et al.
Journal of Microbiology, Immunology and Infection (2017) 50, 427e434Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.e- jmii .comORIGINAL ARTICLEToxic effect of high concentration of
sonochemically synthesized
polyvinylpyrrolidone-coated silver
nanoparticles on Citrobacter sp. A1 and
Enterococcus sp. C1
Chew Ping Lau a, Mohd Firdaus Abdul-Wahab a,
Jafariah Jaafar b, Giek Far Chan c, Noor Aini Abdul Rashid a,*a Faculty of Biosciences and Medical Engineering (FBME), Universiti Teknologi Malaysia (UTM), Johor,
Malaysia
b Faculty of Science, Universiti Teknologi Malaysia (UTM), Johor, Malaysia
c School of Applied Science, Temasek Polytechnic, SingaporeReceived 17 February 2015; received in revised form 20 June 2015; accepted 31 August 2015









1684-1182/Copyright ª 2015, Taiwan S
BY-NC-ND license (http://creativecomAbstract Background/Purpose: Currently, silver nanoparticles (AgNPs) have gained impor-
tance in various industrial applications. However, their impact upon release into the environ-
ment on microorganisms remains unclear. The aim of this study was to analyze the effect of
polyvinylpyrrolidone-capped AgNPs synthesized in this laboratory on two bacterial strains iso-
lated from the environment, Gram-negative Citrobacter sp. A1 and Gram-positive Entero-
coccus sp. C1.
Methods: Polyvinylpyrrolidone-capped AgNPs were synthesized by ultrasound-assisted chemi-
cal reduction. Characterization of the AgNPs involved UVevisible spectroscopy, Fourier trans-
form infrared spectroscopy, X-ray diffraction, transmission electron microscopy, and energy
dispersive X-ray spectroscopy. Citrobacter sp. A1 and Enterococcus sp. C1 were exposed to
varying concentrations of AgNPs, and cell viability was determined. Scanning electron micro-
scopy was performed to evaluate the morphological alteration of both species upon exposure
to AgNPs at 1000 mg/L.
Results: The synthesized AgNPs were spherical in shape, with an average particle size of
15 nm. The AgNPs had different but prominent effects on either Citrobacter sp. A1 or Entero-
coccus sp. C1. At an AgNP concentration of 1000 mg/L, Citrobacter sp. A1 retained viability forFaculty of Biosciences and Medical Engineering (FBME), Universiti Teknologi Malaysia (UTM), 81310
utm.my (N.A. Abdul Rashid).
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428 C.P. Lau et al.6 hours, while Enterococcus sp. C1 retained viability only for 3 hours. Citrobacter sp. A1 ap-
peared to be more resistant to AgNPs than Enterococcus sp. C1. The cell wall of both strains
was found to be morphologically altered at that concentration.
Conclusion: Minute and spherical AgNPs significantly affected the viability of the two bacterial
strains selected from the environment. Enterococcus sp. C1 was more vulnerable to AgNPs,
probably due to its cell wall architecture and the absence of silver resistance-related genes.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Silver nanoparticles (AgNPs; 1e100 nm in size) are attrac-
tive in many industrial applications, especially in the
biomedical field,1 due to their unique physiochemical
properties that are different from those of their parental
bulk silver. AgNP is an excellent antimicrobial agent due to
the well-developed surface and large surface area/volume
ratio, which enhance contact with cell surfaces, allowing
interaction with certain functional groups.2 Various stra-
tegies have been developed for the synthesis of AgNPs
through manipulation of their size, shape, or surface charge
in an effort to improve their antimicrobial property.
There are numerous methods of AgNPs synthesis either
through chemical, physical, photochemical, or biological
routes.3 Chemical reduction of silver ions in different sta-
bilizers is the most common method for production of sta-
ble AgNPs in solution. Additionally, sonochemical
(ultrasound) technique has extensively been used to
generate novel nanomaterials with unusual properties
including silver nanoplates and gold nanorings4 and to
produce minute silver particles rapidly.5
The use of capping agents has been proposed to control
the size and shape of AgNPs. Examples of capping agents
are polyvinylpyrrolidone (PVP), polyvinylamine, amino al-
cohols, polyethylene glycol, or sodium dodecyl sulfate,
which act as stabilizers preventing AgNPs from forming
aggregates or precipitates.6 PVP, in particular, is an
excellent stabilizer due to its unique chemical and physical
properties such as high chemical stability, nontoxicity, and
excellent solubility in many polar solvents.2,7
Bulk silver and silver ions have been used as antimicro-
bial agents for decades.8 The current trend of antimicrobial
agents focuses on nanosized silver, as it is applied to a wide
range of products, including wound dressing, medical de-
vices, clothing, and bedding. AgNPs have been shown to
prevent human immunodeficiency virus (HIV) from attach-
ing to the host cells.9 In addition, Aspergillus niger (fun-
gus), Staphylococcus sp., Bacillus sp. (Gram-positive
bacteria), and Escherichia coli (Gram-negative bacteria)
have also been reported to be susceptible to AgNPs.9
However, the antibacterial mechanism of AgNPs has not
been elucidated thoroughly. Thus far, AgNPs are only known
to inhibit bacterial growth by cell membrane attachment,
penetration, and release into the bacterial cells.10
Several studies have reported on the antibacterial effects
of AgNPs mainly using laboratory strains or clinical patho-
gens.1,8,10,11 It is now known that the release of AgNPs intothe environment increases the contact with the inherent
bacteria. Thus, detailed studies are critical to establish the
effect of AgNPs on native bacteria. In this study, two envi-
ronmental bacterial strains, designated as Citrobacter sp.
A112 and Enterococcus sp. C1 (from here onward designated
as A1 and C1, respectively),13 isolated from a sewage
oxidation pond in Universiti Teknologi Malaysia (Johor,
Malaysia) were used. These bacterial strains have been
studied extensively, especially in relations to the biodegra-
dation of several azo dyes.14 A1 is a Gram-negative cocco-
bacillus from the Enterobacteriaceae family. It has the
potential to be used in heavy metal reduction, nitrate
reduction, sulfate assimilation, quorum sensing, and biofilm
formation, making it important in the biodegradation of
various xenobiotics and bioremediation of heavy metals.12
C1, by contrast, is a Gram-positive facultative anaerobic
diplococcus, classified as lactic acid bacteria.
To date, this study is possibly the first report on the
synthesis of PVP-capped AgNPs by ultrasound-assisted
chemical reduction and subsequent determination of their
antibacterial activity against Citrobacter and Enterococcus
spp. This is a prerequisite to understand the fate of the




Chemicals such as AgNO3 (Merck KGaA, Darmstadt, Ger-
many), NaBH4 (Sigma-Aldrich, St Louis, MO, USA), and PVP
K15 with a molecular weight of around 10,000 (Fluka,
Buchs, Switzerland) are of analytical grade. Glutaralde-
hyde, osmium tetroxide, and sodium cacodylate trihydrate
were bought from Sigma-Aldrich, while all other chemicals
were purchased from Qrec (Auckland, New Zealand). The
two local bacterial strains A1 and C1, formerly isolated
from a sewage oxidation pond, were retrieved from the
culture collection of the Nanomaterials Laboratory, FBME,
UTM. P5 medium (K2HPO4 35.3 g/L, KH2PO4 20.9 g/L, NH4Cl
2 g/L, glucose 10 g/L, nutrient broth 20 g/L, and trace el-
ements) was used as the growth medium.14
Synthesis of AgNPs
The modified ultrasound-assisted chemical reduction
method of Goharshadi and Azizi-Toupkanloo15 was used to
Figure 1. Change in the color of PVP-AgNO3 solution fromclear
to yellow, indicating a reduction of Agþ to Ag0 during synthesis of
AgNPs. AgNPZ silver nanoparticle; PVPZ polyvinylpyrrolidone.
Toxic effect of PVP-AgNPs on microorganisms 429synthesize AgNPs. A solution containing 0.040 g PVP and
0.170 g AgNO3 in 10mLwas prepared. Ice-cold NaBH4 (0.038 g
in 10 mL) was added dropwise into the PVP-AgNO3 solution
and sonicated for 60 minutes in an ultrasonic bath (Branson
3510; Branson Ultrasonics, Danbury, CT, USA). The sonicated
mixture was centrifuged at 13,420 g for 30 minutes, washed
thrice with water, and then freeze dried. AgNP powder was
redispersed in water using ultrasonication before use.
Characterization of AgNPs
The UVevisible spectrum of the AgNP suspension was ac-
quired spectrophotometrically (Shimadzu UV-1601PC; Shi-
madzu, Tokyo, Japan) at room temperature. Fourier
transform infrared spectrum was measured using a Nicolet
IS5-IR spectrometer (Thermo Fisher Scientific, Madison, WI,
USA). AgNP powder was mixed with KBr to form a pellet,
followed by scanning in the range of 400e4000/cm. The X-
ray diffraction (XRD) pattern was recorded over a 2q range
of 30e90 at a scan rate of 1/min using monochromatic Cu
Ka radiation (l Z 1.5406 A˚) with an X-ray powder diffrac-
tometer (Bruker Advance D8; Bruker AXS, Karlsruhe, Ger-
many). Transmission electron microscopy (TEM) and
energy-dispersive X-ray spectroscopy were performed
using a transmission electron microscope (JEOL JEM-2100;
JEOL, Tokyo, Japan) operating at an acceleration voltage
of 200 kV. AgNPs were spiked on a formvar/carbon-coated
copper grid and then air dried. The sample was observed
at magnification ranging from 25,000 to 500,000.
Antibacterial assay
A single colony of A1 or C1 was inoculated separately into
fresh 10 mL P5 medium. The culture was incubated over-
night at 37C with shaking at 200 rpm, until OD600 reached
1.0 0.2. Then, the 2 mL overnight culture was centrifuged
at 1844 g for 5 minutes; the pellet was washed twice with
0.1M phosphate buffer (PB, pH 7) and resuspended in an
equal volume of 0.1 M PB.
A 2-mL bacterial suspension was aliquoted into separate
conical flasks containing 100 mL of 0.1 M PB with varying
concentrations of AgNPs (10 mg/L, 100 mg/L, and 1000 mg/
L), followed by incubation at 30C with shaking at 200 rpm.
Viability of the bacterial cells after exposure was deter-
mined hourly and expressed in terms of colony-forming
units/mL.
Electron microscopic analysis
Cells treated with 1000 mg/L AgNPs in 0.1 M PB were
centrifuged at 295 g for 10 minutes and the pellet was
prefixed with 4% (v/v) glutaraldehyde overnight at 4C. The
prefixed cells were washed with 0.1 M cacodylate buffer
thrice and postfixed with 1% (v/v) osmium tetroxide for 2
hours at 4C. The cells were washed thrice with 0.1 M
cacodylate buffer and dehydrated in a series of ethanol
solutions (35%, 50%, 75%, 95%, and 100%) at 15 minutes
each. The fixed cells were dried and gold-coated on scan-
ning electron microscopy (SEM) stub before observation
under a scanning electron microscope (JEOL JSM-6390LV;
JEOL).Results
Characterization of synthesized AgNPs
The change in the color of the solution from clear to yellow
indicated formation of AgNPs (Figure 1), owing to surface
plasmon resonance16 due to the reduction of Agþ to Ag0. A
single and narrow surface plasmon resonance absorption
band at around 402 nm was observed in the UVevisible
spectrum (Figure 2). This finding, which is in good agree-
ment with several studies suggests that this band can be
attributed to spherical AgNPs.8,17,18
PVP was chosen for capping and stabilizing AgNPs.
Fourier transform infrared spectra corresponding to AgNO3,
PVP, and PVP-capped AgNPs are shown in Figure 3. In the
spectrum of PVP, the peak corresponding to the C]O
stretching at 1658/cm shifted to 1614/cm with the incor-
poration of AgNPs in PVP-capped AgNPs. Additionally, the
CeN stretching peak shifted from 1070/cm (PVP) to 1061/
cm (AgNPs), and the NeOH complex peak, which was at
around 1288/cm in the PVP spectrum, was not observed in
the AgNP spectrum. These three observations suggest that
the AgNPs interacted with PVP, either chemically or
physically.19,20
Size, morphology, and crystallinity of the AgNPs were
examined using XRD and TEM, while the composition of the
nanoparticles was analyzed by energy-dispersive X-ray
spectroscopy. Figure 4A shows the XRD diffraction pattern
of the synthesized AgNPs. Five broad diffraction peaks
observed at 38.1, 44.3, 64.4, 77.5, and 81.5 were
indexed as (111), (200), (220), (311), and (222) planes,
respectively. The result matches the Joint Committee on
Powder Diffraction Standards (JCPDS) database (file no. 04-
9783), indicating that the AgNPs correspond to face-
centered cubic silver (Figure 4B). The broadening of the
diffraction peak implies that the AgNPs formed are minute
particles.15 TEM images of the AgNPs and the histogram for
particle size distribution are shown in Figure 5, exhibiting
particles that are spherical in shape, in the nanosize range
(<65 nm), and widely dispersed. The particle size was
primarily in the range of 2e20 nm, with an average of
15.60 nm. Small-sized AgNPs are useful in many applica-
tions21 and potentially possess greater antibacterial activ-
ity.8,22 The TEM image also shows that the AgNPs are
covered with a layer of PVP (Figure 5B). Interplanar spacing
of synthesized AgNPs is around 0.23 nm, as seen in the TEM
Figure 2. UVevisible spectrum of synthesized AgNPs (150
dilution; inset: the diluted AgNP suspension). AgNP Z silver
nanoparticle.
Figure 4. XRD pattern of (A) AgNPs and (B) pure silver with
FCC symmetry (JCPDS file no. 04-0783). AgNP Z silver nano-
particle; FCCZ face-centered cubic; JCPDSZ Joint Committee
on Powder Diffraction Standards; XRDZ X-ray diffraction.
430 C.P. Lau et al.image (Figure 5C). The energy-dispersive X-ray spectros-
copy spectrum shows the presence of major peaks at
0.3 keV and 3 keV, confirming the presence of PVP and
silver in the AgNPs (Figure 6).Determination of toxicity of AgNPs on A1 and C1
Antibacterial effect of AgNPs
Toxicity of AgNPs toward the model bacterial strains was
investigated according to exposure time and concentration.
Various concentrations of AgNPs, including 0 mg/L, 10 mg/
L, 100 mg/L, and 1000 mg/L, were considered. Bacterial
viability of both A1 and C1 decreased as the concentration
of AgNPs increased (Figure 7).
Gram-negative A1 survived in 0.1M PB with 10 mg/L and
100 mg/L AgNPs after 24 hours of incubation (Figure 7A),
while C1 lost viability after 10 hours of incubation at these
concentrations (Figure 7B). Despite its resilience, at the
AgNP concentration of 1000 mg/L, A1 lost its viability afterFigure 3. FTIR spectra of (A) AgNO3, (B) PVP, and (C) AgNPs
in the presence of PVP. AgNP Z silver nanoparticle; FTIR
Z Fourier transform infrared; PVP Z polyvinylpyrrolidone.6 hours, whereas 3-hour incubation was sufficient for
complete loss of viability of C1. These results indicate that
C1 is more susceptible to AgNPs than A1.
Effect of AgNPs on bacterial cell morphology
Significant morphological changes were observed for the
two strains, as examined under SEM, after treatment with
1000 mg/L AgNPs (Figure 8). Observation was made
following exposure of A1 to AgNPs for 6 hours and of C1 for 3
hours. Both strains were found to have uneven cell surface,
suggesting cell lysis (Figures 8B and 8D). Irregularly shaped
particles are possibly aggregated AgNPs that adhere to
bacterial cells, or perhaps cellular debris.
Discussion
AgNPs may be discharged into the environment during
production and disposal of products containing AgNPs.23
The discharged AgNPs are likely to accumulate in the
aquatic environment leading to contamination, which
impair the function of useful microorganisms in the envi-
ronment. Pseudomonas chlororaphis O6 (a soil bacterium
beneficial to plants) has been reported to lose its cultur-
ability due to AgNPs.11
The appearance of surface plasmon resonance peak in
the UVevisible spectrum of the AgNPs can be associated
with their nanoparticle size, shape, and interparticle in-
teractions and the effects of the surrounding medium on
the nanoparticles.21 The spectrum indicates that AgNPs are
dispersed in nanosize range and are spherical in shape. This
was then confirmed with TEM image and XRD patterns.
The efficacy of AgNPs as antibacterial agent depends
mainly on their size.8,22e25 In this study, AgNPs mostly in the
range of 2e20 nm, with an average size of 15.6 nm, were
synthesized. Smaller particles were assumed to be easily
internalized by microorganisms through the peptidoglycan
and plasma membranes into cytoplasm due to less spatial
hindrance.8,22 The antibacterial activity of AgNPs is partly
due to the release of Agþ from the AgNPs in aqueous
Figure 5. TEM images of AgNPs: (A) at 100,000 magnification, (B) at 250,000 magnification, and (C) at 500,000 magnifi-
cation, and (D) histogram of particle size distribution. AgNP Z silver nanoparticle; PVP Z polyvinylpyrrolidone;
TEM Z transmission electron microscopy.
Toxic effect of PVP-AgNPs on microorganisms 431solution.22 Smaller AgNPs provide greater surface area,
which can rapidly release Agþ via oxidation22,25 and in-
crease the generation of reactive oxidative species (ROS).23
It has been reported that AgNPs of about 15 nm in size
generated more ROS than bigger particles (30 nm and
50 nm), and the ROS are capable of destroying the cell
membrane, DNA, and mitochondria, resulting in cell
death.23
PVP-capped AgNPs are known to possess excellent sta-
bility toward environmental change (including pH change or
ionic strength), making them desirable in the industries.1Figure 6. Elemental analysis of AgNPs using EDX.
AgNP Z silver nanoparticle; EDX Z energy-dispersive X-ray
spectroscopy.The toxicity of AgNPs is dependent not only on the parti-
cle size, but also on the surface charge of the capping
agent.26 PVP-capped AgNPs have increased the tendency of
celleparticle interaction, resulting in higher toxicity,
compared to uncoated H2-AgNPs, citrate-coated AgNPs, and
branched polyethyleneimine-coated AgNPs.26 Thus, PVP has
been selected as the stabilizer for AgNP synthesis.
There are three possible mechanisms of PVP adsorption
onto the nanoparticles: (1) interaction with O atoms only;
(2) interaction with N atoms only; or (3) interaction with
both N and O atoms.27 Figure 3 indicates that the shift of
the Fourier transform infrared band can be associated with
the coordination between PVP with AgNPs, suggesting that
the coordination is possibly via N and O atoms. For particle
size <50 nm, the N atom in PVP coordinated with silver,
forming a protective layer due to the electronegativity of
N, which is lower than that of O.20 Nonetheless, both N and
O are coordinated with silver when steric effect is
strengthened with the increase in diameter of the AgNPs.20
The antibacterial effect of AgNPs on A1 and C1 was first
investigated in rich media: P5 medium and nutrient broth.
Preliminary studies showed that PVP-capped AgNPs did not
affect the viability of A1 and C1 in rich media (data not
shown), probably due to the agglomeration of AgNPs upon
interaction with the organic components from the rich
media24 or due to the bacterial-specific defense mechanism
against AgNPs in nutrient-rich media.28 Therefore, it has
been rationalized that for subsequent investigations,
toxicity studies of AgNPs should be conducted in PB.
It has been demonstrated that PVP-capped AgNPs
completely inhibited the viability of A1 and C1 at 1000 mg/
L. As a comparison, E. coli and Bacillus subtilis completely
Figure 7. Antibacterial effect of AgNPs at concentrations
10e1000 mg/L on (A) Citrobacter sp. A1 and (B) Enterococcus
sp. C1 in 0.1M PB (pH 7) at 30C with shaking at 200 rpm.
AgNP Z silver nanoparticle; CFU Z colony-forming unit;
PB Z phosphate buffer.
Figure 8. SEM images showing the effect of AgNPs on bacterial ce
sp. A1 treated with 1000 mg/L AgNPs in 0.1M PB at 30C with shakin
(D) Enterococcus sp. C1 treated with 1000 mg/L AgNPs in 0.1M PB a
morphological change of the cell). AgNP Z silver nanoparticle; PB
432 C.P. Lau et al.lost viability after 3 hours of exposure to 1.6 mg/L AgNPs in
phosphate buffered saline.29 In another study, the growth
of AgNP-treated Staphylococcus aureus and E. coli were
inhibited at 50 mg/L, while S. aureus and E. coli cells
treated with 100 mg/L AgNPs in MuellereHinton broth lost
viability after 4 hours and 3 hours of exposure, respec-
tively.30 This concentration (at 1000 mg/L of PVP-capped
AgNPs) is relatively high compared to that used in other
studies. This is possibly due to the bacterial resistance, as it
has been suggested that these two strains possess genes
that encode metal ion transporters, and metal-binding or
heavy metal detoxification proteins.12,13
Resistance level to AgNPs was found to vary between the
two strains. This can be associated with the difference in
cell wall architecture; A1, being Gram negative, was
probably more resistant to AgNPs than the Gram-positive
C1. E. coli and Shewanella oneidensis have been reported
to be more tolerant toward AgNPs compared to B. subtilis,
owing to the lipopolysaccharide layer in the outer mem-
brane of these Gram-negative bacteria.31 Hence, the lipo-
polysaccharide layer of A1 may trap and block AgNPs from
entering the cell, as also reported by Lara et al.10
Bacterial genotype also plays an important role in the
defense against AgNPs, as well as against Agþ. Several
strains of bacteria possess genes that encode oxidative
stress protection proteins, damage repair proteins, and
metal efflux pumps, and are involved in the production of
extracellular polymeric substances, resulting in a better
bacterial adaptation and defense against silver.32 For
example, the presence of silB gene in Salmonella serotypesll morphology: (A) untreated Citrobacter sp. A1; (B) Citrobacter
g at 200 rpm for 6 hours; (C) untreated Enterococcus sp. C1; and
t 30C with shaking at 200 rpm for 3 hours (red circles indicate
Z phosphate buffer; SEM Z scanning electron microscope.
Toxic effect of PVP-AgNPs on microorganisms 433assists in its resistance against Agþ, Hg2þ, and tellurite, as
well as against several antibiotics.33 Gram-negative bacte-
ria can also transport Cuþ across the outer membrane to
protect the periplasm from copper-induced damage using
Cus efflux system.34 The system is also involved in silver
detoxification in E. coli.35
P-type ATPases and cation diffusion facilitators may also
be involved in metal resistance, by exporting metal ions
from the cytoplasm to the periplasm, followed by pumping
of the metal ion out of the cell.33 P-type ATPases are coded
by copA gene, which is involved in copper efflux; copA may
be involved in mediating the efflux of silver, since deletion
of the gene resulted in hypersensitivity of E. coli K-12 and
O157:H7 chromosomes to silver, as well as to copper.36 The
previously published draft genome sequence for A1 showed
that the bacterium possesses genes for inner membrane
cation protein (SilA), silver binding protein (SilE), tran-
scriptional regulatory proteins (SilR), copper/silver efflux
system proteins (CusCBA), and sensor/responder system
proteins (CusRS).12 These proteins are commonly reported
in silver- and copper-tolerant bacteria.23,32,36,37 Neverthe-
less, genes coding for these proteins were not identified in
the draft genome sequence of C1.13 The lack of these genes
in C1 probably contributes to its slightly higher sensitivity to
silver as compared to A1.
SEM images suggest physical damages of the AgNPs-
treated bacterial cells, when compared to untreated cells
(Figure 8). Cell damage may be due to direct attachment of
AgNPs to the cell wall and cell membrane of the bacteria,
followed by penetration into the cell. AgNPs preferentially
target bacterial membrane, thus weakening the cell wall,
resulting in dissipation of the proton motive force.11,38
Accumulation of AgNPs in the cell wall increases cell
permeability through disruption of the cell membrane,
inducing cell death. Another possible antimicrobial strategy
is the high affinity of silver towards sulfur and phos-
phorus.39 Thiol-containing proteins and enzymes interact
with AgNPs or Agþ, causing deactivation. Agþ can inactivate
DNA replication by reacting with the phosphorus moieties in
the DNA.39 AgNPs and Agþ have also been suggested to
interact electrostatically with the negative charge in the
cell wall, inducing free radicals, in particular ROS.40
In conclusion, spherical PVP-capped AgNPs (w15 nm in
size) have been synthesized successfully. The synthesized
AgNPs significantly affect the viability of the two environ-
mental isolates A1 and C1. C1 is more susceptible to AgNPs,
as it is Gram positive and does not seem to possess silver-
resistance-related genes. Thus, it can be concluded that
AgNPs released into the environment, upon accumulation,
may have significant impact on the native microorganisms
and the ecosystem.Conflicts of interest
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